Protein kinase C, a Ca2+- and phospholipid-dependent protein phosphorylation enzyme present in myocardium, has been shown recently to induce cardiac beta-adrenergic desensitization by phosphorylation of beta-adrenoceptors. To study whether activation of protein kinase C is responsible for cardiac beta-adrenergic desensitization in congestive heart failure, we propose 1) to compare the number and/or activity of cardiac sarcolemmal protein kinase C in heart failure and sham-operated dogs, 2) to characterize the protein kinase C-catalyzed phosphorylation of endogenous substrate proteins in the myocardium of the heart failure and sham-operated dogs, 3) to study the effect of congestive heart failure on protein kinase C-mediated cellular functions in vitro, using isolated myocyte preparations, 4) to determine whether changes in protein kinase C occur only in the pressure-overloaded right ventricle (chamber-specific) or they are also found in the left ventricle and circulating lymphocytes, and 5) to study whether inhibition of protein kinase C in vivo normalizes myocardial beta-receptor density, adenylate cyclase activity and beta-adrenergic responsiveness in heart failure dogs. Congestive right heart failure will be produced by tricuspid avulsion and progressive pulmonary artery constriction in dogs. Hemodynamic measurements will be taken to characterize the degree of heart failure before the animals are sacrificed. Intrinsic contractile function and inotropic responsiveness of the right ventricle to beta-agonists will be studied, using an isolated right ventricular papillary muscle preparation. Samples will be taken from the right and left ventricles for measuring (3H)-phorbol- 12,13-dibutyrate binding, protein kinase C activity, protein kinase C-catalyze phosphorylation of endogenous substrate proteins, beta- receptor density and adenylate cyclase activity. Isolated myocyte preparations will be used to study the effects of protein kinase C as influenced by congestive heart failure on intracellular hydrogen and calcium concentrations, using fluorescent indicators and spectrofluorimetry. The study incorporates physiological, biochemical and cellular measurements in a conscious animal model. This integrative study will not only further our understanding of the fundamental cellular mechanisms responsible for the decreased sensitivity of the heart to sympathetic stimulation in congestive heart failure, but also may provide us a new modality for the treatment of congestive heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL039260-01
Application #
3355989
Study Section
Cardiovascular and Pulmonary Research B Study Section (CVB)
Project Start
1988-04-01
Project End
1991-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
School of Medicine & Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Qin, Fuzhong; Vulapalli, Raju S; Stevens, Suzanne Y et al. (2002) Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am J Physiol Heart Circ Physiol 282:H363-71
Kawai, H; Fan, T H; Dong, E et al. (1999) ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure. Am J Physiol 277:H1609-17
Raju, V S; Imai, N; Liang, C S (1999) Chamber-specific regulation of heme oxygenase-1 (heat shock protein 32) in right-sided congestive heart failure. J Mol Cell Cardiol 31:1581-9
Dong, E; Yatani, A; Mohan, A et al. (1999) Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol 384:17-24
Lai, L P; Raju, V S; Delehanty, J M et al. (1998) Altered sarcoplasmic reticulum Ca2+ ATPase gene expression in congestive heart failure: effect of chronic norepinephrine infusion. J Mol Cell Cardiol 30:175-85
Yatani, A; Imai, N; Himura, Y et al. (1997) Chronic opiate-receptor inhibition in experimental congestive heart failure in dogs. Am J Physiol 272:H478-84
Lai, L P; Suematsu, M; Elam, H et al. (1996) Differential changes of myocardial beta-adrenoceptor subtypes and G-proteins in dogs with right-sided congestive heart failure. Eur J Pharmacol 309:201-8
Lai, L P; Fan, T H; Delehanty, J M et al. (1996) Elevated myocardial interstitial norepinephrine concentration contributes to the regulation of Na+,K(+)-ATPase in heart failure. Eur J Pharmacol 309:235-41
Himura, Y; Liang, C S; Delehanty, J M et al. (1994) Nitroprusside infusion improves arterial baroreflex control of heart rate in dogs with chronic congestive heart failure. J Cardiovasc Pharmacol 24:702-6
Delehanty, J M; Himura, Y; Elam, H et al. (1994) Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol 266:H930-5

Showing the most recent 10 out of 17 publications